Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLUTION: Losmapimod in COPD
NCT01541852Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jun 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losmapimod in chronic obstructive pulmonary disease (COPD), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Jun 2012; status: completed.
02
Drugs
losmapimod
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01541852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541852.